10.39
+0.0428(+0.41%)
Currency In NaN
| Previous Close | 10.35 |
| Open | 10.38 |
| Day High | 10.39 |
| Day Low | 10.38 |
| 52-Week High | 10.82 |
| 52-Week Low | 10 |
| Volume | 379 |
| Average Volume | 5,182 |
| Market Cap | 239.28M |
| PE | 0 |
| EPS | 0 |
| Moving Average 50 Days | 10.26 |
| Moving Average 200 Days | 10.18 |
| Change | 0.04 |
Drugs Made in America Acquisition Corp. Announces Advisory Team
GlobeNewswire Inc.
Feb 24, 2025 2:30 PM GMT
Fort Lauderdale, FL, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Drugs Made in America Acquisition Corp. (Nasdaq: DMAAU), (the “Company”) today announced the formation of an advisory team to lead its effort towards acquiring a well-managed, revenue generati
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025
GlobeNewswire Inc.
Feb 20, 2025 9:30 PM GMT
Fort Lauderdale, Florida, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) today announced that, commencing February 25, 2025, holders of the units sold in the Company’s initial public offeri
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option
GlobeNewswire Inc.
Feb 18, 2025 9:45 PM GMT
Fort Lauderdale, Florida, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) today announced that the underwriter of its previously announced initial public offering fully exercised its option